Congress Holds Off on Enabling FDA Regulation of Clinical Laboratory-Developed Tests

Feb 27, 2023 | Compliance, Legal, and Malpractice, Laboratory Pathology, Laboratory Resources, Laboratory Sales and Marketing, Laboratory Testing

Supporters of the VALID Act say lobbying blitz by academic medical centers prevented its passage In 2022, a bill before Congress titled the Verifying Accurate Leading-Edge IVCT Development Act (VALID Act) sought to change the current regulatory scheme for clinical laboratory-developed tests (LDTs) and in vitro clinical tests (IVCTs). But even though the College of American Pathologists (CAP) and nine other organizations signed a December 12 stakeholder letter to leaders of key House and Senate...
;